carbostyril has been researched along with Chromosomal Translocation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Batalha, PN; Boechat, FDCS; Costa, ARP; de Moraes, MC; de Souza, MCBV; Muxfeldt, M; Rangel, LP; Silva, JL; Vieira, TCRG | 1 |
| Ågerstam, H; Billström, R; Dreimane, A; Landberg, N; Rissler, M | 1 |
| Eucker, J; Habbel, P; Li, X; Liu, H; Scholz, C; Schulz, CO; Zang, C; Zhou, Y | 1 |
| Beksac, M; Cai, C; Callander, N; Kalimi, G; Reece, D; Scheid, C; Scott, JW; Shi, M; Sonneveld, P; Spencer, A; Stewart, AK | 1 |
| Ebihara, Y; Hanada, S; Imai, K; Konishi, C; Matsuzaka, E; Mochizuki, S; Nakauchi, H; Otsu, M; Takagi, H; Tsuji, K; Yamamoto, S | 1 |
| Cao, HQ; Li, F; Li, HQ; Mei, JG; Qiu, XH; Shao, JJ; Zhai, YP | 1 |
| Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
1 review(s) available for carbostyril and Chromosomal Translocation
| Article | Year |
|---|---|
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
1 trial(s) available for carbostyril and Chromosomal Translocation
| Article | Year |
|---|---|
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 4; Female; Humans; Male; Middle Aged; Multiple Myeloma; Protein Kinase Inhibitors; Quinolones; Recurrence; Retreatment; Translocation, Genetic; Treatment Outcome | 2015 |
5 other study(ies) available for carbostyril and Chromosomal Translocation
| Article | Year |
|---|---|
Aminoquinolones and Their Benzoquinone Dimer Hybrids as Modulators of Prion Protein Conversion.
Topics: Benzoquinones; Humans; Polymers; Prion Diseases; Prion Proteins; Prions; Quinolones; Translocation, Genetic | 2022 |
Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Topics: Benzimidazoles; Chromosomes, Human, Pair 8; Dasatinib; Humans; Imidazoles; Inhibitory Concentration 50; Male; Myeloproliferative Disorders; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcr; Pyridazines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Sequence Analysis, DNA; Translocation, Genetic; Tumor Cells, Cultured; Young Adult | 2017 |
TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic leukemia in vitro.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Drug Synergism; Everolimus; Histone-Lysine N-Methyltransferase; Humans; Infant; Infant, Newborn; Inhibitory Concentration 50; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinolones; Sirolimus; TOR Serine-Threonine Kinases; Translocation, Genetic | 2014 |
Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
Topics: Adolescent; Benzimidazoles; Cells, Cultured; Drug Evaluation, Preclinical; Hematopoiesis; Humans; Imatinib Mesylate; Imidazoles; Induced Pluripotent Stem Cells; Male; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Pyridazines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Staurosporine; Translocation, Genetic | 2015 |
Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
Topics: Animals; Apoptosis; Benzamides; Benzimidazoles; Cell Line; Cell Proliferation; Gene Expression; Humans; Imidazoles; Myeloproliferative Disorders; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins; Pyrazoles; Pyridazines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Translocation, Genetic | 2017 |